Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts123/v4/08/9f/f4/089ff4fd-3d3c-13b1-f390-316f93b577a3/mza_11538209443790692069.jpg/600x600bb.jpg
Precision Neuroscience Reimagined
Akrivia Health
7 episodes
3 days ago
The latest developments, new perspectives, and data-driving research into neuroscience, AI, and clinical trials related to mental health and dementias.
Show more...
Life Sciences
Science
RSS
All content for Precision Neuroscience Reimagined is the property of Akrivia Health and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The latest developments, new perspectives, and data-driving research into neuroscience, AI, and clinical trials related to mental health and dementias.
Show more...
Life Sciences
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/36702357/06e91f55cf6efd8f.jpeg
RWD, Patient-centricity and Clinical Trial Optimisation with Biogen
Precision Neuroscience Reimagined
28 minutes 29 seconds
2 years ago
RWD, Patient-centricity and Clinical Trial Optimisation with Biogen

We are pleased to introduce the podcast series, Precision Neuroscience Reimaged: By Industry, for* Industry. In episode 1, Jane Twichen, Head, Clinical Trial Accelerator Unit & Senior Director, Global Clinical Operations, and Sarah Deeley, Senior Clinical Country Lead, at Biogen, joined Tina Marshall, Head of Commercial at Akrivia Health to discuss barriers in clinical trials and how to overcome them, why the UK is an attractive place for clinical trials, and what steps we need to take to make the UK a global hub for life sciences.  


- - - - -

Produced by Clarity Video: https://clarityvideo.co.uk/video-services/podcast-production/

- - - - -

Precision Neuroscience Reimagined
The latest developments, new perspectives, and data-driving research into neuroscience, AI, and clinical trials related to mental health and dementias.